Search research articles
Contact Us
Filters
Showing results (21-30 of 126) with videos related to
Page
of 13
Sort By:
Clinical Endocrinology
|
July 5, 2012
The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis
Malay Rana, Craig F Munns, Hiran Selvadurai, et al.
Frontiers in Endocrinology
|
December 17, 2020
Editorial: Childhood Rickets-New Developments in Epidemiology, Prevention, and Treatment
Peter J Simm, Craig F Munns, Craig Alan Jefferies, et al.
Nature Reviews. Endocrinology
|
May 26, 2010
Cystic fibrosis-related diabetes in children--gaps in the evidence?
Malay Rana, Craig F Munns, Hiran Selvadurai, et al.
Pediatric Rheumatology Online Journal
|
October 4, 2014
Proprioceptive acuity into knee hypermobile range in children with joint hypermobility syndrome
Verity Pacey, Roger D Adams, Louise Tofts, et al.
Hormone Research in Paediatrics
|
September 21, 2013
Intravenous zoledronic Acid given every 6 months in childhood osteoporosis
Hooi Leng Ooi, Julie Briody, Andrew Biggin, et al.
Journal of Paediatrics and Child Health
|
January 28, 2015
Quality of life prediction in children with joint hypermobility syndrome
Verity Pacey, Louise Tofts, Roger D Adams, et al.
Pediatric Rheumatology Online Journal
|
August 15, 2013
Exercise in children with joint hypermobility syndrome and knee pain: a randomised controlled trial comparing exercise into hypermobile versus neutral knee extension
Verity Pacey, Louise Tofts, Roger D Adams, et al.
The American Journal of Sports Medicine
|
July 6, 2010
Generalized joint hypermobility and risk of lower limb joint injury during sport: a systematic review with meta-analysis
Verity Pacey, Leslie L Nicholson, Roger D Adams, et al.
Archives of Disease in Childhood
|
May 28, 2014
Joint hypermobility syndrome subclassification in paediatrics: a factor analytic approach
Verity Pacey, Roger D Adams, Louise Tofts, et al.
Hormone Research in Paediatrics
|
February 14, 2015
The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta
Andrew Biggin, Linda Zheng, Julie N Briody, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 126) with videos related to
Sort By:
Page
of 13
Clinical Endocrinology
|
July 5, 2012
The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis
Malay Rana, Craig F Munns, Hiran Selvadurai, et al.
Frontiers in Endocrinology
|
December 17, 2020
Editorial: Childhood Rickets-New Developments in Epidemiology, Prevention, and Treatment
Peter J Simm, Craig F Munns, Craig Alan Jefferies, et al.
Nature Reviews. Endocrinology
|
May 26, 2010
Cystic fibrosis-related diabetes in children--gaps in the evidence?
Malay Rana, Craig F Munns, Hiran Selvadurai, et al.
Pediatric Rheumatology Online Journal
|
October 4, 2014
Proprioceptive acuity into knee hypermobile range in children with joint hypermobility syndrome
Verity Pacey, Roger D Adams, Louise Tofts, et al.
Hormone Research in Paediatrics
|
September 21, 2013
Intravenous zoledronic Acid given every 6 months in childhood osteoporosis
Hooi Leng Ooi, Julie Briody, Andrew Biggin, et al.
Journal of Paediatrics and Child Health
|
January 28, 2015
Quality of life prediction in children with joint hypermobility syndrome
Verity Pacey, Louise Tofts, Roger D Adams, et al.
Pediatric Rheumatology Online Journal
|
August 15, 2013
Exercise in children with joint hypermobility syndrome and knee pain: a randomised controlled trial comparing exercise into hypermobile versus neutral knee extension
Verity Pacey, Louise Tofts, Roger D Adams, et al.
The American Journal of Sports Medicine
|
July 6, 2010
Generalized joint hypermobility and risk of lower limb joint injury during sport: a systematic review with meta-analysis
Verity Pacey, Leslie L Nicholson, Roger D Adams, et al.
Archives of Disease in Childhood
|
May 28, 2014
Joint hypermobility syndrome subclassification in paediatrics: a factor analytic approach
Verity Pacey, Roger D Adams, Louise Tofts, et al.
Hormone Research in Paediatrics
|
February 14, 2015
The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta
Andrew Biggin, Linda Zheng, Julie N Briody, et al.
Page
of 13